gnipst bulletin 24.2.pdf

7/28/2019 GNIPST BULLETIN 24.2.pdf

1/20

1118-1177-4796-9849-7562-5062mail

GNIPST BULLETIN 2013

05th April 2013 Volume No.: 24 Issue No.: 02

ContentsMessage from GNIPS

Letter to the EditorNews Update

Disease Outbreak Ne

Health Awareness

Forth Coming Events

Drugs Update

Campus News

Students Section

Editors Note

Archive

Vision

TO GROW AS A CENTRE OF EXCELLENCE IN THE FIELD O

PHARMACEUTICAL AND BIOLOGICAL SCIENCE

EDITOR:DebabrataGhoshDastidarGURU NANAK INSTITUTE OF PHARMACEUTICAL SCIENCE ANDTECHNOLOGY

GNIPST Photo Gallery

For your comments/contributionOR

For Back-Issues,

mailto:[email protected]

1
https://picasaweb.google.com/111714720327580099858/SeminarPresentationmailto:[email protected]:[email protected]:[email protected]://picasaweb.google.com/111714720327580099858/SeminarPresentation


2/20

05-04-2013

MESSAGE FROM GNIPSTAll the members of GNIPST are proud to publish the 24th Volume

of GNIPST BULLETIN. This bulletin has successfully

completed its twenty months journey. We hope it haskept the

readersupdated of recent activities in pharmaceutical & biological

sciences and also introduced them with the different activities of

our esteemed institution. We are thankful to all of you for your

great cooperation & support and are looking forward to the samein

future.

LETTER TO THE EDITOR.

NEWS UPDATE

WORLD HEALTH DAY 2013: 07 April

To mark World Health Day on 7 April, WHO is calling for

intensified efforts to prevent and control hypertension, also

known as high blood pressure. Worldwide, high blood pressure is

estimated to affect more than one in three adults aged 25 and over,

or about one billion people. Hypertension is a major contributor to

heart disease and stroke which together make up the worlds

number one cause of premature death and disability.Read more

Click here to go at the top1
http://www.who.int/campaigns/world-health-day/2013/en/index.htmlhttp://www.who.int/campaigns/world-health-day/2013/en/index.htmlhttp://www.who.int/campaigns/world-health-day/2013/en/index.htmlhttp://www.who.int/campaigns/world-health-day/2013/en/index.html


3/20

05-04-2013

HIV Self-Testing: The Key to Controlling the

Global Epidemic(02 APRIL 2013)

A new international study has confirmed that self-testing for HIVis effective and could be the answer to controlling the global

epidemic. This systematic review shows HIV self-testing removes

much of the fear and stigma associated with being tested for the

disease. This study could pave the way for early detection and

treatment around the world, thereby reducing transmission. Readmore

Feeling Hungry May Protect the Brain Against

Alzheimer's Disease (02 APRIL 2013)

A study in mice with genetic mutations seen in human

Alzheimer's disease found that the feeling of hunger itself mayprotect against the disease.Read more

White Blood Cell Enzyme Contributes to

Inflammation and Obesity(02 APRIL 2013)

Researchers have discovered that an imbalance between the

enzyme neutrophil elastase and its inhibitor, 1-antitrypsin, causes

inflammation, obesity, insulin resistance, and fatty liver disease.

Read more

http://www.sciencedaily.com/releases/2013/04/130402182638.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130402182638.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130402182638.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130402182457.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130402182457.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130402163250.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130402163250.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130402182457.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130402182638.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130402182638.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29


4/20

05-04-2013

Decreased Melatonin Secretion Associated With

Higher Risk of Developing Type 2 Diabetes

(02 APRIL 2013)

With previous evidence suggesting that melatonin may have a role

in glucose metabolism, researchers have found an independent

association between decreased secretion of melatonin and an

increased risk for the development of type 2 diabetes.Read moreHow Antibodies Neutralize Mosquito-Borne Virus

(02 APRIL 2013)

Researchers have learned the precise structure of the mosquito-

transmitted chikungunya virus pathogen while it is bound toantibodies, showing how the infection is likely neutralized. Readmore

Baldness Linked to Increased Risk of Coronary

Heart Disease(03 APRIL 2013)

Male pattern baldness is linked to an increased risk of coronary

heart disease, but only if it's on the top/crown of the head, rather

than at the front, a new analysis finds.Read more Potential Therapy for Human Prion Disease.

(03 APRIL 2013)

http://www.sciencedaily.com/releases/2013/04/130402162420.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130402162420.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130402125044.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130402125044.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130403200156.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130403200156.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130403200156.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130402125044.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130402125044.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130402162420.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29


5/20

05-04-2013

Scientists have for the first time identified a pair of drugs already

approved for human use that show anti-prion activity and, for one

of them, great promise in treating rare and universally fatal

disorders, such as Creutzfeldt-Jakob disease, caused by misfoldedproteins called prions.Read more

Will Cell Therapy Become a 'Third Pillar' of

Medicine? (03 APRIL 2013)

Treating patients with cells may one day become as common as it

is now to treat the sick with drugs made from engineered proteins,

antibodies or smaller chemicals, according to UC San Francisco

researchers. They have outlined their vision of cell-based

therapeutics as a "third pillar of medicine.Read more Immune System: The Healing Element Is Also

the Enemy(03 APRIL 2013)

The same factor in our immune system that is instrumental in

enabling us to fight off severe and dangerous inflammatory

ailments is also a player in doing the opposite at a later stage,

causing the suppression of our immune response.Read moreVaccine Adjuvant Uses Host DNA to Boost

Pathogen Recognition(05 APRIL 2013)

http://www.sciencedaily.com/releases/2013/04/130403154305.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130403154305.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130403141434.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130403141434.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130403072003.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130403072003.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130403072003.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130403141434.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130403154305.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29


6/20

05-04-2013

Aluminum salts, or alum, have been injected into billions of people

as an adjuvant to make vaccines more effective. No one knows,

however, how they boost the immune response. Researchers

continue unraveling the mystery of adjuvants with a report that

host DNA coats the alum adjuvant and induces two crucial cells to

interact twice as long during the initial stimulation of the adaptive

immune system.Read more.

HEALTH AWARENESS

CARDIOVASCULAR DISEASES

What are cardiovascular diseases?

Cardiovascular diseases (CVDs) are a group of

disorders of the heart and blood vessels andthey include:

coronary heart disease

disease of the blood vessels supplying the heart

muscle;

cerebrovascular disease - disease of the blood vessels

supplying the brain;

peripheral arterial disease disease of blood vessels

supplying the arms and legs;

http://www.sciencedaily.com/releases/2013/04/130405184630.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130405184630.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/04/130405184630.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29


7/20

05-04-2013

rheumatic heart disease damage to the heart muscle

and heart valves from rheumatic fever, caused by

streptococcal bacteria;

congenital heart disease - malformations of heart

structure existing at birth;

deep vein thrombosis and pulmonary embolism blood

clots in the leg veins, which can dislodge and move to the

heart and lungs.

Heart attacks and strokes are usually acute events and are

mainly caused by a blockage that prevents blood from flowing to

the heart or brain. The most common reason for this is a build-up

of fatty deposits on the inner walls of the blood vessels that

supply the heart or brain. Strokes can also be caused by bleeding

from a blood vessel in the brain or from blood clots.

What are the risk factors for cardiovascular disease?

The most important behavioural risk factors of heart disease and

stroke are unhealthy diet, physical inactivity, tobacco use andharmful use of alcohol. Behavioural risk factors are responsible

for about 80% of coronary heart disease and cerebrovascular

disease.



8/20

05-04-2013

The effects of unhealthy diet and physical inactivity may show

up in individuals as raised blood pressure, raised blood glucose,

raised blood lipids, and overweight and obesity. These

intermediate risks factors can be measured in primary care

facilities and indicate an increased risk of developing a heart

attack, stroke, heart failure and other complications.

Cessation of tobacco use, reduction of salt in the diet, consuming

fruits and vegetables, regular physical activity and avoidingharmful use of alcohol have been shown to reduce the risk of

cardiovascular disease. The cardiovascular risk can also be

reduced by preventing or treating hypertension, diabetes and

raised blood lipids.

Policies that create conducive environments for making healthy

choices affordable and available are essential for motivating

people to adopt and sustain healthy behavior.

There are also a number of underlying determinants of CVDs, or

"the causes of the causes". These are a reflection of the major

forces driving social, economic and cultural change

globalization, urbanization, and population ageing. Other

determinants of CVDs include poverty, stress and hereditary

factors.



9/20

05-04-2013

What are common symptoms of cardiovascular diseases?

Symptoms of heart attacks and strokes

Often, there are no symptoms of the underlying disease of the

blood vessels. A heart attack or stroke may be the first warning

of underlying disease. Symptoms of a heart attack include:

pain or discomfort in the centre of the chest;

pain or discomfort in the arms, the left shoulder, elbows,

jaw, or back.

In addition the person may experience difficulty in breathing or

shortness of breath; feeling sick or vomiting; feeling light-headed

or faint; breaking into a cold sweat; and becoming pale. Women

are more likely to have shortness of breath, nausea, vomiting, and

back or jaw pain.

The most common symptom of a stroke is sudden weakness of

the face, arm, or leg, most often on one side of the body. Other

symptoms include sudden onset of:

numbness of the face, arm, or leg, especially on one side ofthe body;

confusion, difficulty speaking or understanding speech;

difficulty seeing with one or both eyes;



10/20

05-04-2013

difficulty walking, dizziness, loss of balance or

coordination;

severe headache with no known cause; and fainting or

unconsciousness.

People experiencing these symptoms should seek medical care

immediately.

What is rheumatic heart disease?

Rheumatic heart disease is caused by damage to the heart valves

and heart muscle from the inflammation and scarring caused by

rheumatic fever. Rheumatic fever is caused by streptococcal

bacteria, which usually begins as a sore throat or tonsillitis in

children.

Rheumatic fever mostly affects children in developing countries,

especially where poverty is widespread. Globally, almost 2% of

deaths from cardiovascular diseases is related to rheumatic heart

disease, while 42% of deaths from cardiovascular diseases is

related to ischaemic heart disease, and 34% to cerebrovascular

disease.

Symptoms of rheumatic heart disease



11/20

05-04-2013

Symptoms of rheumatic heart disease include: shortness of

breath, fatigue, irregular heart beats, chest pain and

fainting.

Symptoms of rheumatic fever include: fever, pain and

swelling of the joints, nausea, stomach cramps and

vomiting.

Treatment

Early treatment of streptococcal sore throat can stop the

development of rheumatic fever. Regular long-term penicillin

treatment can prevent repeat attacks of rheumatic fever which

give rise to rheumatic heart disease and can stop disease

progression in people whose heart valves are already damaged by

the disease.

Why are cardiovascular diseases a development issue in low-

and middle-income countries?

Over 80% of the world's deaths from CVDs occur in low-

and middle-income countries.

People in low- and middle-income countries are more

exposed to risk factors such as tobacco, leading to CVDs



12/20

05-04-2013

and other noncommunicable diseases. At the same time

they often do not have the benefit of prevention

programmes compared to people in high-income

countries.

People in low- and middle-income countries who suffer

from CVDs and other noncommunicable diseases have

less access to effective and equitable health care services

which respond to their needs (including early detection

services).As a result, many people in low- and middle-income countries

die younger from CVDs and other noncommunicable diseases,

often in their most productive years.

The poorest people in low- and middle-income countries are

affected most. At the household level, sufficient evidence is

emerging to prove that CVDs and other noncommunicable

diseases contribute to poverty due to catastrophic health

spending and high out of pocket expenditure.

At macro-economic level, CVDs place a heavy burden on the

economies of low- and middle-income countries.

Noncommunicable disease including cardiovascular disease and

diabetes are estimated to reduce GDP by up to 6.77% in low- and

middle-income countries experiencing rapid economic growth,

as many people die prematurely.



13/20

05-04-2013

How can the burden of cardiovascular diseases be reduced?

Very cost effective interventions that are feasible to be

implemented even in low resource settings have been identified

by WHO for prevention and control of cardiovascular diseases.

Heart disease and stroke can be prevented through healthy diet,

regular physical activity and avoiding tobacco smoke.

Individuals can reduce their risk of CVDs by engaging in regularphysical activity, avoiding tobacco use and second-hand tobacco

smoke, choosing a diet rich in fruit and vegetables and avoiding

foods that are high in fat, sugar and salt, and maintaining a

healthy body weight and avoiding the harmful use of alcohol.

Comprehensive and integrated action is the means to prevent

and control CVDs.

Comprehensive action requires combining approaches

that seek to reduce the risks throughout the entire

population with strategies that target individuals at high

risk or with established disease.

Examples of population-wide interventions that can be

implemented to reduce CVDs include: comprehensive tobacco

control policies, taxation to reduce the intake of foods that are



14/20

05-04-2013

high in fat, sugar and salt, building walking and cycle paths to

increase physical activity, providing healthy school meals to

children.

Integrated approaches focus on the main common risk

factors for a range of chronic diseases such as CVD,

diabetes and cancer: unhealthy diet, physically inactivity

and tobacco use.

There are several intervention options available. Some of these

interventions can be implemented even by non-physician healthworkers in close- to- client facilities. They are very cost effective

and high impact interventions and have been prioritized by

WHO. For example:

People at high risk can be identified early in primary care,

using simple tools such as specific risk prediction charts.

If people are identified early, inexpensive treatment is

available to prevent many heart attacks and strokes.

Survivors of a heart attack or stroke are at high risk of

recurrences and at high risk of dying from them. The risk

of a recurrence or death can be substantially lowered

with a combination of drugs statins to lowercholesterol, drugs to lower blood pressure, and aspirin.

In addition surgical operations are sometimes required to

treat CVDs. They include coronary artery bypass, balloon



15/20

05-04-2013

angioplasty (where a small balloon-like device is

threaded through an artery to open the blockage), valve

repair and replacement, heart transplantation, and

artificial heart operations.

Medical devices are required to treat some CVDs. Such

devices include pacemakers, prosthetic valves, and

patches for closing holes in the heart.

There is a need for increased government investment inprevention and early detection through national programmes

aimed at prevention and control of noncommunicable

diseases including CVDs.



16/20

05-04-2013

DISEASE OUTBREAK NEWS

FORTHCOMING EVENTS

DRUGS UPDATES

FDA approves Invokana to treat type 2

diabetes. (29 MARCH 2013)The U.S. FDA approved Invokana (canagliflozin) tablets, used with

diet and exercise, to improve glycemic control in adults with type

2 diabetes.Read moreFDA approves new multiple sclerosis treatment:

Tecfidera(27 MARCH 2013)The U.S. FDA approved approved Tecfidera (dimethylfumarate) capsules to treat adults with relapsing forms ofm ultiple sclerosis (M S).Read more

CAMPUS NEWS

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345848.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345848.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345848.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345528.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345528.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345528.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345528.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345848.htm


17/20

05-04-2013

STUDENTS SECTION

WHO CAN ANSWER FIRST???() Which analytical principle was invented by

Archer J Martin and Richard Synge?

() In 1996 which pharmaceutical company wascreated from the merging of two pharma

companies: Ciba Geigy and Sandoz

Laboratories?Answer of Previous Issue Question:

A) Ranitidine B) Confocal ImagingCongratulation Sreemanti Mazumder, B.Pharm final year,

for correct answer.

Send yourthoughts/ Quiz/Puzzles/games/write-ups or any other contributions for Students Section

& answers of this Section at [email protected]

mailto:[email protected]:[email protected]:[email protected]


18/20

05-04-2013

EDITORS NOTE

I am very happy to publish the 2nd issue of 24th Volume of GNIPST

BULLETIN. It is my great pleasure to introduce you to the newly

launched facebook account GNIPST bulletin. You are cordially

invited to add this account to your friend list. The current issues will

also be directly available on facebook.

I would like to convey my thanks to all the GNIPST members and

the readers for their valuable comments, encouragement& supports.

Special thanks to Dr. Prerona Saha for her advice; Mr. Soumya

Bhattacharya, for his contribution instudents section.

It would be my great pleasure to receive the contributions,

suggestions & feedback from your desk for further upliftment of this

deliberation GNIPST BULLETIN.



19/20

05-04-2013

ARCHIVE

The general body meeting of APTI, Bengal Branch has been

conducted at GNIPST on 15th

June, 2012. The programme startedwith a nice presentation by Dr. Pulok Kr. Mukherjee, School of

Natural Products, JU on the skill to write a good manuscript for

publication in impact journals. It was followed by nearly two hour

long discussion among more than thirty participants on different

aspects of pharmacy education. Five nonmember participants

applied for membership on that very day.

GNIPST is now approved by AICTE and affiliated to WBUT for

conducting the two years post graduate course (M.Pharm) in

P H A R M A C O L O G Y . The approved number of seat is 18.The number of seats in B.Pharm. has been increased from 60 to

120.

2nd World Congress on Ga-68 (Generators and Novel Radiopharmaceuticals),

Molecular Imaging (PET/CT), Targeted Radionuclide Therapy, and

Dosimetry (SWC-2013) : On the Way to Personalized Medicine

Dates 28 Feb 2013

02 Mar 2013Location: Chandigarh, India.Details.

http://www.2ndworldcongress-ga-68.de/http://www.2ndworldcongress-ga-68.de/http://www.2ndworldcongress-ga-68.de/http://www.2ndworldcongress-ga-68.de/


20/20

05-04-2013

AICTE has sanctioned a release of grant under Research

Promotion Scheme (RPS) during the financial year 2012-

13to GNIPST as per the details below:

a. Beneficiary Institution: Guru Nanak Institution of

Pharmaceutical Science & Technology.

b. Principal Investigator: Dr. LopamudraDutta.

c. Grant-in-aid sanctioned:Rs. 16,25000/- only

d. Approved duration: 3 years

e. Title of the project: Screening and identification ofpotential medicinal plant of Purulia&Bankuradistricts of West

Bengal with respect to diseases such as diabetes, rheumatism,

Jaundice, hypertension and developing biotechnological tools for

enhancing bioactive molecules in these plant.

Cli k h h

gnipst bulletin 24.2.pdf

Documents